What Ultragenyx Pharmaceutical Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 5 | 28 |
| Total trades | 5 | 52 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 458,630 |
| Disposed | 15,106 | 165,668 |
| Net activity | −15,106 | +292,962 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Horn Howard | Chief Financial Officer | Oct 15 | Sale for tax withholding · S | −7,066 | $15.27 | −$108K | 89,229 |
| Huizenga Theodore Alan | SVP, Chief Accounting Officer | Sep 15 | Open-market sale · S | −1,283 | $13.57 | −$17.4K | 67,863 |
| Huizenga Theodore Alan | SVP, Chief Accounting Officer | Sep 03 | Sale for tax withholding · S | −161 | $13.99 | −$2.25K | 69,146 |
| Parschauer Karah Herdman | EVP and Chief Legal Officer | Aug 03 | Open-market sale · S | −1,900 | $24.92 | −$47.3K | 92,562 |
| Horn Howard | Chief Financial Officer | Aug 03 | Open-market sale · S | −4,696 | $24.92 | −$117K | 96,295 |
| Horn Howard | Chief Financial Officer | Jul 01 | Open-market sale · S | −4,698 | $33.13 | −$156K | 100,991 |
| Parschauer Karah Herdman | EVP and Chief Legal Officer | Jun 15 | Open-market sale · S | −1,899 | $24.62 | −$46.8K | 94,462 |
| Sanders Corazon (Corsee) D. | Director | Jun 15 | Open-market sale · S | −2,000 | $25.05 | −$50.1K | 21,095 |
| Horn Howard | Chief Financial Officer | Jun 01 | Open-market sale · S | −4,653 | $23.77 | −$111K | 105,689 |
| Suliman Shehnaaz | Director | May 18 | Open-market sale · S | −5,740 | $25.12 | −$144K | 27,951 |
| Dunsire Deborah | Director | May 14 | Grant / award · A | +7,751 | — | — | 38,566 |
| Welch Daniel G | Director | May 14 | Grant / award · A | +7,751 | — | — | 40,441 |
| Suliman Shehnaaz | Director | May 14 | Grant / award · A | +7,751 | — | — | 33,691 |
| Fust Matthew K | Director | May 14 | Grant / award · A | +7,751 | — | — | 33,696 |
| Sanders Corazon (Corsee) D. | Director | May 14 | Grant / award · A | +7,751 | — | — | 23,095 |
| Narachi Michael | Director | May 14 | Grant / award · A | +7,751 | — | — | 40,441 |
| Ray Amrit | Director | May 14 | Grant / award · A | +7,751 | — | — | 31,116 |
| Crombez Eric | EVP and Chief Medical Officer | May 05 | Sale for tax withholding · S | −344 | $24.96 | −$8.59K | 111,189 |
| Horn Howard | Chief Financial Officer | May 01 | Open-market sale · S | −4,683 | $24.90 | −$117K | 110,342 |
| Huizenga Theodore Alan | SVP, Chief Accounting Officer | Apr 22 | Grant / award · A | +20,241 | — | — | 68,911 |
Loading...
